Fusion glycoprotein (92-106)_product_DataBase

Bioactivity	Fusion glycoprotein 92-106 is a polypeptide from fusion protein of respiratory syncytial virus (RSV). Fusion glycoprotein 92-106 acts as MHC class I-restricted CTL epitope, that all 15 amino acids are required for efficient recognition by cytotoxic T lymphocyte (CTL)[1].
Invitro	Fusion glycoprotein 92-106 形成 Kd 重链和 β2-微球蛋白复合物[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Fusion glycoprotein (92-106) 相关抗体:
In Vivo	Fusion glycoprotein 92-106 (100 μg，皮下注射，每周两次，持续 3 周) 可在 BALB/c 小鼠模型中诱导针对 RSV 感染的保护性免疫反应[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model:
CAS	406477-46-1
Sequence	Glu-Leu-Gln-Leu-Leu-Met-Gln-Ser-Thr-Pro-Pro-Thr-Asn-Asn-Arg
Shortening	ELQLLMQSTPPTNNR
Formula	C73H124N22O25S
Molar Mass	1741.96
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Jiang S, et al., Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus. J Gen Virol. 2002 Feb;83(Pt 2):429-438.

PeptideDB